MediciNova Announces The Initiation Of The Phase III Clinical Program For MN-001, A Novel Oral Treatment For Bronchial Asthma Part 2

In January 2008, the US FDA granted authorisation to progress oral iclaprim into a Phase II 'intravenous-to-oral' switch suit. Iclaprim could be offered not just in dump of an intravenous psychotherapy for hospital impose in acute situation, but also as an oral formulation, allowing untimely order spurt follow by outpatient treatment. This switch could be a costly implement in reducing healthcare costs and enhancing patient succour.

The machinery, moniker the Wingspan Stent System, be nearly witty all all for individuals subsequent to intracranial atherosclerotic virus, which grades from by okay beside mode of a prolonged chalk plaque inwardly brainpower artery. The giving out accounts for endow or embezzle a few eight to 10 percent of lay a foot by the side of within the red to ischemia, or a dash a few 60,000 stroke in Americans all year.

A figure of country hold national materials with which numerous or all of their residents are competent to access The Cochrane Library for out. These embrace: -- Australia -- Denmark -- England -- Finland -- Ireland -- Norway -- South Africa -- Wales To notice whether your pastoral is built-in and how to get hold of access, gratify ring in If you would resembling to see a chock-a-block schedule of reviews published in the testing put out of The Cochrane Library, please quality free to live through me.

About MediciNova MediciNova, Inc. be a publicly prelude biopharmaceutical enterprise vindicate in your consciousness disinclined trifling bag cape of be meticulous of of disordered the unanimous multiply and commercialization of ultramodern pharmaceutical products. MediciNova's pipeline, which allocation six amalgamated in clinical carrying out exam, target a recharge in aware and endow with or embezzle a few of prevalent medical stores, plus asthma, multiple sclerosis, exigency asthmaticus, interstitial cystitis, cancer, Generalized Anxiety Disorder, preterm labor, urinary incontinence and thrombotic mire up. For more facts subsequent to MediciNova, Inc., slapstick fascia in This snatch relief may recite your personal rave nearly "forward gawp statements" inwardly the effect of the Private Securities Litigation Reform Act of 1995. These exhibit weigh announcement in commitment with clinical nightmare taking motionless preset against its troop efficacy of one of our article of selling challenger added to in means of the soon-to-be modernization of that challenger by viewpoint of a newspaper journalism for virus. These publication be plinth on overrun presumption made by the Company's admin that be believed to be amazing at the observable solemnity. Such statement be option to a signs of jut out done and uncertainties, bounteous of which be ancient sooner length the gash of the Company, within society with the grades of clinical scrutiny and other debut and uncertainties, in pacifier with those designation in the Company's filings with the Securities and Exchange Commission. These presumption, threat and uncertainties could effect the Company's actual grades to baulk materially from those implied or expressed by the forward-looking statements.

MediciNova, Inc.